Status:
UNKNOWN
ReAl-life multIceNter Outcomes Registry for Better antithrOmbotic Strategies in Patients With AF (RAINBOW-AF)
Lead Sponsor:
Henan Provincial People's Hospital
Conditions:
Atrial Fibrillation
Anticoagulant Therapy
Eligibility:
All Genders
Brief Summary
Anticoagulation therapy is the most important part of the treatment strategy for atrial fibrillation. Previous studies have confirmed that both warfarin and new oral anticoagulants can effectively pre...
Detailed Description
The project is carried out in 30 research centers across the country, and the research object is the prescription/medical order data of real-world atrial fibrillation patients (outpatient and inpatien...
Eligibility Criteria
Inclusion
- Patients with incident (initial diagnosis) AF (Atrial Fibrillation) with electrocardiographic documentation or patients with prevalent (existing diagnosis) AF who had initiation or transition to a NOAC
- Anticipated ability to adhere to local regularly scheduled follow-up visits
Exclusion
- Atrial flutter only
- Anticipated life expectancy less than 6 months
- Atrial fibrillation caused by reversible factors, such as hyperthyroidism, acute myocardial infarction, acute pulmonary embolism, etc.
- Active bleeding, such as intracranial hemorrhage, gastrointestinal bleeding, etc.
- Patients with deep vein thrombosis, pulmonary embolism, artificial hip/knee replacement and other anticoagulation indications
- Participation in a randomized trial of anticoagulation for AF at the time of enrollment
Key Trial Info
Start Date :
September 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT05361889
Start Date
September 1 2022
End Date
August 1 2025
Last Update
May 19 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.